Showing results (161-170 of 316) with videos related to
Sort By:
Pageof 32
Cancers|August 12, 2023
Systematic Review of Photodynamic Therapy in GliomasTiffaney Hsia, Julia L Small, Anudeep Yekula, et al.Expert Review of Clinical Pharmacology|August 10, 2013
An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastomaPatrick C Gedeon, Bryan D Choi, Tiffany R Hodges, et al.Pediatric Neurosurgery|August 17, 2013
Inflammatory pseudotumor of the lateral ventricle in a pediatric patientBryan D Choi, Tiffany R Hodges, Gerald A Grant, et al.Interdisciplinary Neurosurgery : Advanced Techniques and Case Management|May 22, 2018
Sporadic NF2 Mosaic: Multiple spinal schwannomas presenting with severe, intractable pain following pregnancyJeffrey H Zimering, Bryan D Choi, Matthew J Koch, et al.Journal for Immunotherapy of Cancer|November 1, 2025
Chimeric antigen receptor (CAR) T-cell therapy for glioblastoma (GBM): current clinical insights, challenges, and future directionsChase M Walton, Marcus Bell, Richard O'Neil, et al.World Neurosurgery|January 9, 2018
Interaction Between the Contributions of Tumor Location, Tumor Grade, and Patient Age to the Survival Benefit Associated with Gross Total ResectionKate T Carroll, Alex K Bryant, Brian Hirshman, et al.Journal of Neuro-Oncology|June 20, 2020
Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell stateTyler C Steed, Jeffrey M Treiber, Birra Taha, et al.Critical Care Medicine|July 9, 2005
Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhageNeeraj Badjatia, Mehmet A Topcuoglu, Ferdinando S Buonanno, et al.Journal of Neuro-Oncology|May 16, 2013
Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastomaJ Dawn Waters, Brent Rose, David D Gonda, et al.Pharmacology & Therapeutics|May 19, 2024
Altered cancer metabolism and implications for next-generation CAR T-cell therapiesRishab Ramapriyan, Vivasvan S Vykunta, Gust Vandecandelaere, et al.Pageof 32